MGWM
Marks Group Wealth Management’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $274K | Sell |
1,477
-666
| -31% | -$124K | 0.03% | 263 |
|
2025
Q1 | $449K | Buy |
2,143
+69
| +3% | +$14.5K | 0.04% | 247 |
|
2024
Q4 | $369K | Buy |
2,074
+5
| +0.2% | +$889 | 0.04% | 240 |
|
2024
Q3 | $409K | Sell |
2,069
-79
| -4% | -$15.6K | 0.04% | 234 |
|
2024
Q2 | $368K | Sell |
2,148
-111
| -5% | -$19K | 0.04% | 241 |
|
2024
Q1 | $411K | Buy |
2,259
+5
| +0.2% | +$910 | 0.04% | 236 |
|
2023
Q4 | $349K | Buy |
2,254
+63
| +3% | +$9.76K | 0.04% | 241 |
|
2023
Q3 | $327K | Buy |
2,191
+5
| +0.2% | +$745 | 0.04% | 236 |
|
2023
Q2 | $295K | Sell |
2,186
-635
| -23% | -$85.6K | 0.04% | 250 |
|
2023
Q1 | $450K | Buy |
2,821
+598
| +27% | +$95.3K | 0.06% | 217 |
|
2022
Q4 | $359K | Buy |
2,223
+5
| +0.2% | +$808 | 0.05% | 231 |
|
2022
Q3 | $297K | Buy |
2,218
+6
| +0.3% | +$803 | 0.05% | 237 |
|
2022
Q2 | $339K | Buy |
2,212
+114
| +5% | +$17.5K | 0.05% | 237 |
|
2022
Q1 | $340K | Buy |
2,098
+253
| +14% | +$41K | 0.04% | 261 |
|
2021
Q4 | $249K | Buy |
+1,845
| New | +$249K | 0.03% | 285 |
|